JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $5.45M | ﹤0.01% |
95,751
-8,445,258
| -99% | -$464M |
|
|
NEX
2502
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $5.43M | ﹤0.01% |
285,955
-65,050
| -19% | -$1.02M |
|
|
CLR
2503
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.42M | ﹤0.01% |
102,330
-1,385,410
| -93% | -$60.8M |
|
2504
PUT
PPG Industries
PPG
$25.5B
| $5.42M | ﹤0.01% |
46,400
+7,500
| +19% | +$865K |
|
|
ESPR
2505
DELISTED
Esperion Therapeutics
ESPR
| $5.42M | ﹤0.01% |
82,261
+20,461
| +33% | +$1.1M |
|
2506
iShares Short Maturity Bond ETF
NEAR
$4.88B
| $5.42M | ﹤0.01% |
108,037
+5,136
| +5% | +$258K |
|
|
CDR
2507
DELISTED
Cedar Realty Trust, Inc
CDR
| $5.41M | ﹤0.01% |
134,864
+28,353
| +27% | +$1.1M |
|
|
ORAN
2508
DELISTED
Orange
ORAN
| $5.41M | ﹤0.01% |
310,733
+17,658
| +6% | +$295K |
|
|
MCHB
2509
Mechanics Bancorp
MCHB
$3.79B
| $5.37M | ﹤0.01% |
185,426
+33,826
| +22% | +$981K |
|
2510
Nabors Industries
NBR
$1.35B
| $5.37M | ﹤0.01% |
15,723
-56,659
| -78% | -$18M |
|
2511
PUT
Dollar Tree
DLTR
$24.9B
| $5.37M | ﹤0.01% |
50,000
-141,000
| -74% | -$13.8M |
|
2512
FirstService
FSV
$6.18B
| $5.36M | ﹤0.01% |
116,618
+23,134
| +25% | +$1.59M |
|
2513
CALL
EQT Corp
EQT
$33.8B
| $5.36M | ﹤0.01% |
+172,862
| New | +$5.67M |
|
2514
Seres Therapeutics
MCRB
$45M
| $5.35M | ﹤0.01% |
26,391
+7,724
| +41% | +$1.59M |
|
2515
Ingersoll Rand
IR
$32.7B
| $5.35M | ﹤0.01% |
157,580
-5,401
| -3% | -$161K |
|
2516
Sabesp
SBS
$16.5B
| $5.35M | ﹤0.01% |
2,638,881
-24,453
| -0.9% | -$47K |
|
|
TGE
2517
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $5.34M | ﹤0.01% |
207,656
-6,544
| -3% | -$164K |
|
2518
Steven Madden
SHOO
$3.46B
| $5.34M | ﹤0.01% |
171,453
+101,454
| +145% | +$2.84M |
|
2519
CALL
International Paper
IP
$21.8B
| $5.34M | ﹤0.01% |
97,258
| – | – |
|
2520
Standex International
SXI
$3.97B
| $5.32M | ﹤0.01% |
52,253
+18,697
| +56% | +$1.93M |
|
2521
Rigel Pharmaceuticals
RIGL
$762M
| $5.31M | ﹤0.01% |
136,876
-2,989
| -2% | -$114K |
|
|
GNBC
2522
DELISTED
Green Bancorp, Inc
GNBC
| $5.3M | ﹤0.01% |
260,914
-19,245
| -7% | -$427K |
|
2523
iShares Mortgage Real Estate ETF
REM
$547M
| $5.29M | ﹤0.01% |
116,968
+26,737
| +30% | +$1.23M |
|
2524
CALL
Philip Morris
PM
$294B
| $5.28M | ﹤0.01% |
50,000
-25,000
| -33% | -$2.66M |
|
|
CHMI
2525
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $5.28M | ﹤0.01% |
293,547
+227,511
| +345% | +$4.17M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.